Clinical Trials
- Arthritis
Yale Rheumatology Program Patient Registry and Bio-Repository
- Ages18 years - 99 years
- GenderBoth
- Immune System
Yale Lupus and Connective Tissue Disease Bio-Repository / Yale Rheumatology Bio-Repository
- Ages18 years and older
- GenderBoth
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Children's Health, Immune System, Arthritis
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Ages2 years - 21 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Myasthenia Gravis Inebilizumab Trial (MINT)
- Ages18 years and older
- GenderBoth
- Orthopaedics, Muscle & Bone, Immune System
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE (NAIVE)
- Ages18 years - 70 years
- GenderBoth
- Orthopaedics, Muscle & Bone
test
- Ages16 years and older
- GenderBoth
- Leukemia
Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
- Immune System
Inhibition of Sterile Inflammation by Digoxin
- Ages18 years - 70 years
- GenderBoth
- Phase 1 Cancers
test